{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:30:13Z","timestamp":1773293413086,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,10,1]]},"DOI":"10.1038\/sj.bmt.1702625","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:48:20Z","timestamp":1031154500000},"page":"859-864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin\u2019s lymphoma (NHL): results of a provincial strategy"],"prefix":"10.1038","volume":"26","author":[{"given":"AD","family":"Schimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Messner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Meharchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Huebsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Benger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Ontario BMT Network Ontario Canada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,10,24]]},"reference":[{"key":"BF1702625_CR1","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V92.2.405","volume":"92","author":"J Blay","year":"1998","unstructured":"Blay J, Gomez F, Sebban C et al. The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial Blood 1998 92: 3562\u20133568","journal-title":"Blood"},{"key":"BF1702625_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma New Engl J Med 1995 333: 1540\u20131545","journal-title":"New Engl J Med"},{"key":"BF1702625_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma New Engl J Med 1987 316: 1493\u20131498","journal-title":"New Engl J Med"},{"key":"BF1702625_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0002-9343(89)80152-4","volume":"87","author":"JM Vose","year":"1989","unstructured":"Vose JM, Armitage JO, Bierman PJ et al. Salvage therapy for relapsed or refractory non-Hodgkin\u2019s lymphoma utilizing autologous bone marrow transplantation Am J Med 1989 87: 285\u2013288","journal-title":"Am J Med"},{"key":"BF1702625_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/sj.bmt.1701245","volume":"21","author":"N Kroger","year":"1998","unstructured":"Kroger N, Hoffknecht M, Hanel M et al. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy Bone Marrow Transplant 1998 21: 1171\u20131175","journal-title":"Bone Marrow Transplant"},{"key":"BF1702625_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.bmt.1700772","volume":"19","author":"AP Rapoport","year":"1997","unstructured":"Rapoport AP, Lifton R, Constine LS et al. Autotransplantation for relapsed or refractory non-Hodgkin\u2019s lymphoma (NHL): long-term follow-up and analysis of prognostic factors Bone Marrow Transplant 1997 19: 883\u2013890","journal-title":"Bone Marrow Transplant"},{"key":"BF1702625_CR7","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","volume":"90","author":"LF Verdonck","year":"1997","unstructured":"Verdonck, LF, Dekker AW, Lokhorst HM et al. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin\u2019s lymphoma Blood 1997 90: 4201\u20134205","journal-title":"Blood"},{"key":"BF1702625_CR8","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data J Clin Oncol 1992 10: 1690\u20131695","journal-title":"J Clin Oncol"},{"key":"BF1702625_CR9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Chatchada K et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma Blood 1994 84: 1050\u20131055","journal-title":"Blood"},{"key":"BF1702625_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 157","journal-title":"J Am Stat Assoc"},{"key":"BF1702625_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34B","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables J Roy Stat Soc 1972 34B: 187","journal-title":"J Roy Stat Soc"},{"key":"BF1702625_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1200\/JCO.1998.16.1.48","volume":"16","author":"PJ Siff","year":"1998","unstructured":"Siff PJ, Dahlberg S, Forman SJ et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin\u2019s lymphoma: a value of augmented preparative regimens \u2013 a Southwest Oncology Group trial J Clin Oncol 1998 16: 48\u201355","journal-title":"J Clin Oncol"},{"key":"BF1702625_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","volume":"20","author":"MD Caballero","year":"1997","unstructured":"Caballero MD, Rubio V, Rifon J et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors Bone Marrow Transplant 1997 20: 451\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"BF1702625_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"77","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambiner RF, Piantadosi S et al. Evidence of a graft-versus lymphoma effect associated with allogeneic bone marrow transplantation Blood 1991 77: 649\u2013653","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702625","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:04:25Z","timestamp":1733569465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,10,1]]}},"alternative-id":["BF1702625"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702625","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,1]]},"assertion":[{"value":"7 February 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}